Viewing Study NCT06467357

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 6:32 PM

Ignite Modification Date: 2026-01-05 @ 5:17 AM

Study NCT ID: NCT06467357

Status: RECRUITING

Last Update Posted: 2025-10-27

First Post: 2024-05-21

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Sponsor: AstraZeneca

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module